Qualigen Therapeutics, Inc. — Director's Dealing 2017

Feb 1, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RITTER PHARMACEUTICALS INC (RTTR)
CIK: 0001460702
Period of Report: 2017-01-25

Reporting Person: Merino William M. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-25	Non-qualified Stock Option (Right to Buy)	$2.89	A	10000	Acquired	2027-01-25	Common Stock (10000)	Direct

Footnotes

F1: 25% of the shares underlying the option will vest on January 17, 2018. The remaining 75% of the shares underlying the option will vest in 36 equal monthly installments beginning on February 17, 2018 with the balance vesting on the 17th day of each calendar month thereafter.